Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.

Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check5 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study record content, effectively making the NCT01844115 page inaccessible to users.SummaryDifference17%

- Check54 days agoChange DetectedRevision metadata updated from v3.6.5 to v3.6.6, indicating a minor maintenance update to the page. It does not reflect changes to the study details or outcomes.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page shows a new Revision: v3.6.5, replacing the prior v3.6.4, indicating a site version update rather than a change to study information.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small update to the page's version information.SummaryDifference0.0%

Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.